XERIS BIOPHARMA HOLDINGS INC (XERS) Stock Cash Flow
NASDAQ:XERS - Nasdaq - US98422E1038 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.08M | -54.84M | -62.26M | -94.66M | -122.73M | |||
| Depreciation Amortization | 12.73M | 12.63M | 13.16M | 12.24M | 1.88M | |||
| Income Taxes - Deferred | -2.58M | -2.27M | -1.25M | -1.42M | N/A | |||
| Change In Working Capital | -12.43M | -8.82M | -6.29M | -35.15M | 11.85M | |||
| Interest Paid | 25.45M | 26.95M | 27.69M | 10.86M | 7.29M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 20.64M | 16.32M | 9.62M | 16.10M | 13.46M | |||
| OPERATING CASH FLOW | -26.71M | -36.98M | -47.02M | -102.89M | -95.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -717.00K | -868.00K | -2.26M | -520.00K | -1.09M | |||
| Other Investing Activity | 25.24M | 5.75M | -3.74M | 34.99M | 99.05M | |||
| INVESTING CASH FLOW | 24.52M | 4.88M | -6.00M | 34.46M | 97.96M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 50.00M | 0.00 | 101.98M | 0.00 | |||
| Stock Issued/Repurchased | -2.16M | -2.00M | -428.00K | 30.37M | 27.30M | |||
| Other Financing Activity | 0.00 | -11.83M | -1.19M | -4.88M | -50.00K | |||
| FINANCING CASH FLOW | -2.16M | 36.17M | -1.61M | 127.47M | 27.25M | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| CHANGE IN CASH | -4.35M | 4.07M | -54.64M | 59.04M | 29.67M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -26.71M | -36.98M | -47.02M | -102.89M | -95.54M | |||
| Capital Expenditure | -717.00K | -868.00K | -2.26M | -520.00K | -1.09M | |||
| FREE CASH FLOW | -27.43M | -37.85M | -49.29M | -103.41M | -96.63M | |||
All data in USD